Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Xenon Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer producing branded medicines across multiple therapeutic and dosage-form categories.

Xenon Pharmaceuticals products in Pakistan

Xenon Pharmaceuticals (Pvt.) Ltd has 78 medicine presentations registered in Pakistan under 42 brands, covering 35 generic medicines. Most of its products are in CNS & mental health, Anti-infectives and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Recitan (Levetiracetam), Xeepam (Diazepam), Vetrox (Ceftriaxone) and Profox (Ciprofloxacin). 78 products have an official DRAP price on MedInfoBase. See all 42 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check26 Sep 2026Latest source-check date across this published portfolio
Latest effective price date25 Sep 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Xenon Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
9.5 K.M Sheikhupura Road, Lahore 54000, Pakistan · 54000
Phone
+92 42 37921108; +92 42 37929540
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000077 Xenon Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000077 78 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx80public portfolio records represented
REG58unique registrations represented
IDX0indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER18registry-verified exact registrations
PKR78current validated price records
G35generic molecules in indexed catalogue
DF10dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage97%
priced packs safely normalized per unit
Comparable-market coverage60%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixXenon Pharmaceuticals (Pvt.) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/xenon-pharmaceuticals-pvt-ltdGenerated 14 Nov 2026CNS & mental health26 · 33%Anti-infectives21 · 27%Gastrointestinal & hepatology7 · 9%Pain & musculoskeletal6 · 8%Cross-therapeutic & anti-inflamma…5 · 6%Cardiovascular4 · 5%Dermatology3 · 4%Other therapeutic areas6 · 8%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioXenon Pharmaceuticals (Pvt.) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/xenon-pharmaceuticals-pvt-ltdGenerated 14 Nov 202678presentationsTablet33 · 42%Solution13 · 17%Suspension9 · 12%Injection5 · 6%Syrup5 · 6%Capsule4 · 5%Other forms9 · 12%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionXenon Pharmaceuticals (Pvt.) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/xenon-pharmaceuticals-pvt-ltdGenerated 14 Nov 202647comparable productsBelow peer median32 · 68%Near peer median9 · 19%Above peer median6 · 13%Company median price position-21.2%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsXenon Pharmaceuticals (Pvt.) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/xenon-pharmaceuticals-pvt-ltdGenerated 14 Nov 2026Nabiqasim Industries (Pvt) Ltd.,24 shared69% overlapNeutro Pharma (Pvt.) Ltd.,24 shared69% overlapPharmasol (Pvt) Ltd.22 shared63% overlapGlobal Pharmaceuticals (Pvt.) Ltd.20 shared57% overlapM/s. Genix Pharma (Pvt) Ltd.19 shared54% overlapValor Pharmaceuticals19 shared54% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet33 products
Solution13 products
Suspension9 products
Injection5 products
Syrup5 products
Capsule4 products
Other4 products
Cream3 products
Ointment1 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Xenon Pharmaceuticals (Pvt.) Ltd is priced against the market

47 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers57Distinct registrations among indexed, published, presentation-validated products only
Verified price observations154
Products with a verified price78
Products with multiple price observations76
Source records with multiple versions78
Latest portfolio source check26 Sep 2026
Latest effective price date25 Sep 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

58 unique registration(s) · 0 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
No matching products.
A to Z

All 42 Xenon Pharmaceuticals brands in Pakistan

  • Aspirin Acetylsalicylic acid (Aspirin) · 300 mg tablet
  • Ateplex Clopidogrel · 75 mg tablet
  • Basix Liquid Furosemide · 10 mg oral liquid
  • Cefkan Cefixime · 400 mg capsule, 600 mg suspension
  • Debritone Phenobarbital · 30 mg tablet
  • Debritone Elixir Phenobarbital · 4 mg solution
  • Dermistat Miconazole · 2 % cream
  • DEXAMETHASONE Dexamethasone · 0.5 mg tablet
  • Disone Betamethasone · 0.5 mg ointment
  • Doxin Liquid Digoxin · 0.05 mg/ml liquid
  • Flunco Fluconazole · 10 mg/ml suspension, 150 mg capsule
  • Hydrocortisone Hydrocortisone · 10mg cream
  • Kasamol Paracetamol · 120 mg suspension
  • Korat Loratadine · 10 mg tablet
  • ODN Ondansetron · 4 mg/5 mL solution
  • ODN-4 Ondansetron · 4 mg tablet
  • ODN-8 Ondansetron · 8 mg tablet
  • Omrazo Omeprazole · 20 mg capsule, 40 mg capsule
  • Osmolarz-ORS Sodium chloride · 1.3 g sachet
  • PARACETAMOL Paracetamol · 500 mg tablet
  • Preloid Prednisolone · 5 mg syrup
  • Profox Ciprofloxacin · 125 mg suspension, 250 mg tablet, 500 mg tablet
  • Profox Forte Ciprofloxacin · 250 mg suspension
  • Ready Amitriptyline · 25 mg tablet
  • Recitan Levetiracetam · 250 mg tablet, 500 mg tablet, 500 mg/5ml solution
  • Regard Risperidone · 1 mg tablet, 2 mg tablet
  • Respirate Salbutamol · 5 mg solution
  • Siltran Trimethoprim · 80 mg tablet
  • Siltran D.S Trimethoprim · 160mg tablet
  • Steron Prednisolone · 15 mg syrup
  • Vetrox Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Xeclom Clomifene citrate · 50 mg tablet
  • Xedol Albendazole · 200 mg tablet
  • Xeeazo Azithromycin · 200 mg suspension, 250 mg tablet
  • Xeepam Diazepam · 2 mg tablet, 5 mg solution, 5 mg tablet
  • Xelak Lactulose · 3.35 g syrup
  • Xepulse Midazolam · 7.5 mg tablet
  • Xetac Ranitidine · 150mg tablet
  • Xothium Lithium carbonate · 400 mg tablet
  • Yoxi Moxifloxacin · 400 mg tablet
  • Zefen Ibuprofen · 100 mg suspension
  • Zekavir Entecavir · 0.5 mg tablet
Questions

Xenon Pharmaceuticals: common questions

How many products does Xenon Pharmaceuticals have in Pakistan?

Xenon Pharmaceuticals (Pvt.) Ltd has 78 registered medicine presentations in Pakistan, sold under 42 brands and covering 35 generic medicines.

What are the main brands of Xenon Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Recitan (Levetiracetam), Xeepam (Diazepam), Vetrox (Ceftriaxone), Profox (Ciprofloxacin) and Zefen (Ibuprofen). This is not a sales ranking.

Which therapy areas does Xenon Pharmaceuticals cover?

The most products are in CNS & mental health (26), Anti-infectives (21), Gastrointestinal & hepatology (7), Pain & musculoskeletal (6) and Cross-therapeutic & anti-inflammatory (5).

Where can I see Xenon Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Xenon Pharmaceuticals (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 14, 2026, from https://medinfobase.com/company/xenon-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9